Radek RJ

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : Effects of the novel alpha7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA\/2 mice: pharmacodynamic characterization - Radek_2012_J.Pharmacol.Exp.Ther_343_736
Author(s) : Radek RJ , Robb HM , Stevens KE , Gopalakrishnan M , Bitner RS
Ref : Journal of Pharmacology & Experimental Therapeutics , 343 :736 , 2012
Abstract : Radek_2012_J.Pharmacol.Exp.Ther_343_736
ESTHER : Radek_2012_J.Pharmacol.Exp.Ther_343_736
PubMedSearch : Radek_2012_J.Pharmacol.Exp.Ther_343_736
PubMedID: 22988063

Title : Poster: Positive allosteric modulation of alpha4\/beta2 nicotinic receptors potentiates some CNS effects of the alpha4\/beta2 agonist, ABT-594 -
Author(s) : Franklin SR , Mohler EG , Komater VA , Robb H , Radek RJ , Rustay NR , Brown JW , Gopalakrishnan M , Decker MW , Rueter LE
Ref : Biochemical Pharmacology , 78 :921 , 2009
PubMedID:

Title : Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor - Faghih_2009_J.Med.Chem_52_3377
Author(s) : Faghih R , Gopalakrishnan SM , Gronlien JH , Malysz J , Briggs CA , Wetterstrand C , Ween H , Curtis MP , Sarris KA , Gfesser GA , El-Kouhen R , Robb HM , Radek RJ , Marsh KC , Bunnelle WH , Gopalakrishnan M
Ref : Journal of Medicinal Chemistry , 52 :3377 , 2009
Abstract : Faghih_2009_J.Med.Chem_52_3377
ESTHER : Faghih_2009_J.Med.Chem_52_3377
PubMedSearch : Faghih_2009_J.Med.Chem_52_3377
PubMedID: 19419141

Title : Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties - Tietje_2008_CNS.Neurosci.Ther_14_65
Author(s) : Tietje KR , Anderson DJ , Bitner RS , Blomme EA , Brackemeyer PJ , Briggs CA , Browman KE , Bury D , Curzon P , Drescher KU , Frost JM , Fryer RM , Fox GB , Gronlien JH , Hakerud M , Gubbins EJ , Halm S , Harris R , Helfrich RJ , Kohlhaas KL , Law D , Malysz J , Marsh KC , Martin RL , Meyer MD , Molesky AL , Nikkel AL , Otte S , Pan L , Puttfarcken PS , Radek RJ , Robb HM , Spies E , Thorin-Hagene K , Waring JF , Ween H , Xu H , Gopalakrishnan M , Bunnelle WH
Ref : CNS Neurosci Ther , 14 :65 , 2008
Abstract : Tietje_2008_CNS.Neurosci.Ther_14_65
ESTHER : Tietje_2008_CNS.Neurosci.Ther_14_65
PubMedSearch : Tietje_2008_CNS.Neurosci.Ther_14_65
PubMedID: 18482100

Title : Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1\/2 and CREB phosphorylation pathways - Bitner_2007_J.Neurosci_27_10578
Author(s) : Bitner RS , Bunnelle WH , Anderson DJ , Briggs CA , Buccafusco JJ , Curzon P , Decker MW , Frost JM , Gronlien JH , Gubbins E , Li J , Malysz J , Markosyan S , Marsh K , Meyer MD , Nikkel AL , Radek RJ , Robb HM , Timmermann DB , Sullivan JP , Gopalakrishnan M
Ref : Journal of Neuroscience , 27 :10578 , 2007
Abstract : Bitner_2007_J.Neurosci_27_10578
ESTHER : Bitner_2007_J.Neurosci_27_10578
PubMedSearch : Bitner_2007_J.Neurosci_27_10578
PubMedID: 17898229

Title : Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA\/2 mouse model of sensory gating - Radek_2006_Psychopharmacology.(Berl)_187_47
Author(s) : Radek RJ , Miner HM , Bratcher NA , Decker MW , Gopalakrishnan M , Bitner RS
Ref : Psychopharmacology (Berl) , 187 :47 , 2006
Abstract : Radek_2006_Psychopharmacology.(Berl)_187_47
ESTHER : Radek_2006_Psychopharmacology.(Berl)_187_47
PubMedSearch : Radek_2006_Psychopharmacology.(Berl)_187_47
PubMedID: 16767415

Title : ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization - Bannon_1998_J.Pharmacol.Exp.Ther_285_787
Author(s) : Bannon AW , Decker MW , Curzon P , Buckley MJ , Kim DJ , Radek RJ , Lynch JK , Wasicak JT , Lin NH , Arnold WH , Holladay MW , Williams M , Arneric SP
Ref : Journal of Pharmacology & Experimental Therapeutics , 285 :787 , 1998
Abstract : Bannon_1998_J.Pharmacol.Exp.Ther_285_787
ESTHER : Bannon_1998_J.Pharmacol.Exp.Ther_285_787
PubMedSearch : Bannon_1998_J.Pharmacol.Exp.Ther_285_787
PubMedID: 9580627

Title : Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties - Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50
Author(s) : Arneric SP , Sullivan JP , Decker MW , Brioni JD , Bannon AW , Briggs CA , Donnelly-Roberts D , Radek RJ , Marsh KC , Kyncl J , Williams M , Buccafusco JJ
Ref : Alzheimer Disease & Associated Disorders , 9 Suppl 2 :50 , 1995
Abstract : Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50
ESTHER : Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50
PubMedSearch : Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50
PubMedID: 8534424